SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors anticipate a major catalyst from the REGAL Phase 3 trial, with active discussion centered on imminent survival data, institutional positioning, and buyout potential. The community remains polarized, with vocal longs betting on a structural paradigm shift in cancer treatment while skeptical voices highlight clinical trial uncertainties and the speculative nature of recent price volatility.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing high-volume discussions driven by a mix of long-term investor anticipation regarding a potential eBay acquisition and significant skepticism toward social media figures accused of promoting the stock for personal gain. While bulls highlight improving financial guidance and fundamental turnaround efforts, the community remains deeply polarized by the lack of immediate price catalysts and the persistent presence of speculative meme stock comparisons.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is seeing heavy social sentiment as investors debate its potential for a long-term turnaround while navigating a period of significant price compression. Community members are actively analyzing transaction data and technical supply constraints, while simultaneously tracking volatility surrounding broader market shifts.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility and heavy trading volume as investors debate the impact of index rebalancing and lingering buyout rumors. Community sentiment remains polarized, with many shareholders expressing frustration over stagnant performance and leadership, while others point to the company's strong revenue and potential pipeline catalysts as reasons to hold.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing significant community discussion as investors weigh the stock's long-term potential as an enterprise AI workflow leader against recent price volatility and sector-wide software pressure. While retail sentiment remains split between concerns over enterprise software valuation and bullish conviction in the companys strong renewal rates and AI-driven growth, the stock is being actively monitored for signs of a technical reversal and potential rotation into SaaS assets.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as investors debate the impact of newly unveiled drone technology alongside ongoing frustration regarding a lack of significant contract announcements. While the community remains divided over potential government support and the stock's future performance, discussions are heavily focused on the company's ability to transition from a R&D-focused entity into a scalable defense supplier.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is trending as investors debate the sustainability of its rapid expansion and market valuation, with discussions centered on its critical role in the Indium Phosphide substrate supply chain for AI data center optics. While some community members point to a strong order backlog and structural AI demand as catalysts, others express caution due to recent insider share sales, potential dilution, and persistent geopolitical and export-permit risks.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing market attention following the FDA approval of Lumvoa, the first treatment for Thyroid Eye Disease (TED) with labeling that covers both active and chronic forms of the disease. Investors and the community are actively debating the company's commercial launch roadmap and competitive positioning against existing blockbusters, with many looking toward the upcoming conference call for insights on pricing, insurance coverage, and long-term revenue potential.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is facing intense community debate as holders grapple with its current price levels, leading to a split between those who view the decline as a buying opportunity and those labeling the project a failed or abandoned venture. While some participants continue to promote the token's ecosystem potential and long-term viability, widespread skepticism persists regarding its utility and future performance compared to newer meme coins.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending following market speculation that potential hyperscaler interest in OpenAI's data center infrastructure may signal an upcoming contract win for the company's Texas campus. The community is actively debating the credibility of these rumors and the ongoing governance battle between current management and the former CEO, as investors look for a binding tenant agreement to validate the stock's long-term infrastructure thesis.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

5 Best U.S. Mid Cap Growth ETFs to Own Long Term  
$FPX - First Trust US Equity Opportunities ETF 
$XMMO - Invesco S&amp;P MidCap Momentum ETF 
$FAD - First Trust Multi Cap Growth AlphaDEX® Fund 
$IMCG - iShares Morningstar Mid-Cap Growth ETF 
$FNY - First Trust Mid Cap Growth AlphaDEX® Fund  
 
https://x.com/MicahMcDonald8/status/2070511934919831617?s=20

Goku

X (Formerly Twitter)

Semi-Retired Blue Collar Guy on X (formerly Twitter): "https://t.co/OkO30bxXIj / X"

StockTwits Web

First Trust Exchange-Traded Fund III - First Trust US Equity Opportunities ETF

Invesco S&P MidCap Momentum ETF

First Trust Exchange-Traded Fund III - First Trust Multi Cap Growth AlphaDEX Fund

iShares Morningstar Mid-Cap Growth ETF

First Trust Exchange-Traded Fund III - First Trust Mid Cap Growth AlphaDEX Fund

5 Best U.S. Mid Cap Growth ETFs to Own Long Term  


 - First Trust US Equity Opportunities ETF 


 - First Trust Multi Cap Growth AlphaDEX® Fund 


 - iShares Morningstar Mid-Cap Growth ETF 


 - First Trust Mid Cap Growth AlphaDEX® Fund  
 
